The Safety,Efficacy of Anti-EGFR Humanized Monoclonal Antibody Combined With Chemotherapy in Advanced Solid Tumors.

clinical trial

The Safety,Efficacy of Anti-EGFR Humanized Monoclonal Antibody Combined With Chemotherapy in Advanced Solid Tumors. is …
instance of (P31):
clinical trialQ30612

External links are
P3098ClinicalTrials.gov IDNCT03577704

P6099clinical trial phasephase I clinical trialQ5452194
phase II clinical trialQ42824440
P582end time2021-09-30
P4135maximum age75
P2899minimum age18
P1132number of participants90
P4844research interventioncalcium oxalateQ412399
cisplatinQ412415
carboplatinQ415588
paclitaxelQ423762
immunological antineoplastic agentQ50429626
P6153research siteShanghai East HospitalQ30296399
P1813short nameHLX07Ib/II
P580start time2018-08-08
P8363study typeinterventional studyQ78089383
P1476titleAn Exploratory Study on the Safety, Tolerability, Pharmacokinetics and Efficacy of HLX07 (Recombinant Anti-EGFR Humanized Monoclonal Antibody) Combined With Chemotherapy in Patients With Advanced Solid Tumors.

Search more.